Case reports on the innovative treatment option for persistent and drug refractory atrial fibrillation accompanying with tachycardia induced cardiomyopathy with LVEF of 25-30%.

Back

ACNAP Premium Access

Case reports on the innovative treatment option for persistent and drug refractory atrial fibrillation accompanying with tachycardia induced cardiomyopathy with LVEF of 25-30%.

Session: Clinical cases - On demand

Topic: Clinical

Speaker: Doctor Y. Lee (Newport Beach, US)

Event: ACNAP-EuroHeartCare 2022

Congress Presentation

Add to my library

About the speaker

Doctor Yasmine Lee

Hoag Memorial Hospital Presbyterian, Newport Beach (United States of America)

1 presentation

1 follower

5 more presentations in this session

Survival following recurrent sustained ventricular tachycardia in a low-resource setting: challenges of management.

Speaker: Doctor T. Shogade (Uyo, NG)

Access

Slides

Video

From STEMI to MitraClip.

Speaker: Mrs D. Levy (Haifa, IL)

Access

Slides

Video

Role of Cardiac Rehabilitation in a case of AV block of indeterminate etiology.

Speaker: Doctor G. Shenoy (Mumbai, IN)

Access

Slides

Video

Infective endocarditis care during COVID-19 pandemic.

Speaker: Assistant Professor I. Matic (Zagreb, HR)

Access

Slides

Video

Atrial septal aneurysm type 4LR in a 60 year old male with RCA thrombosis.

Speaker: Doctor C. Canaveral (Metro Manila, PH)

Access

Slides

Video

Access the full session

Clinical cases - On demand

Speakers: Doctor Y. Lee, Doctor T. Shogade, Mrs D. Levy, Doctor G. Shenoy, Assistant Professor I. Matic...

Access

About the event

ACNAP-EuroHeartCare 2022

22 May - 23 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources